Foresite Capital Management V

Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ALMS, CGON, IRON, HIMS, PHVS, and represent 87.94% of Foresite Capital Management V's stock portfolio.
  • Added to shares of these 3 stocks: PHVS (+$16M), Odyssey Therapeutics (+$13M), CGON (+$5.3M).
  • Started 1 new stock position in Odyssey Therapeutics.
  • Reduced shares in these 2 stocks: MAZE, LYEL.
  • Sold out of its position in MAZE.
  • Foresite Capital Management V was a net buyer of stock by $34M.
  • Foresite Capital Management V has $362M in assets under management (AUM), dropping by 33.66%.
  • Central Index Key (CIK): 0001792206

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management V

Foresite Capital Management V holds 9 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alumis (ALMS) 45.8 $166M 5.9M 28.14
 View chart
Cg Oncology (CGON) 21.2 $77M +7% 1.1M 71.05
 View chart
Disc Medicine (IRON) 7.6 $27M 374k 73.14
 View chart
Hims & Hers Health Com Cl A (HIMS) 7.1 $26M 738k 34.67
 View chart
Pharvaris N V (PHVS) 6.3 $23M +242% 664k 34.58
 View chart
Eikon Therapeutics (EIKN) 4.8 $17M 1.3M 13.05
 View chart
Odyssey Therapeutics 3.7 $13M NEW 713k 18.71
 View chart
Lyell Immunopharma (LYEL) 1.8 $6.7M 476k 14.05
 View chart
Nurix Therapeutics (NRIX) 1.8 $6.4M 265k 24.26
 View chart

Past Filings by Foresite Capital Management V

SEC 13F filings are viewable for Foresite Capital Management V going back to 2020

View all past filings